Navigation Links
Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry
Date:6/22/2009

SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- DIA 45th Annual Meeting --

News Facts

  • In a new report, IDC Health Insights, an advisory services and market research firm focused on the healthcare and life science markets, ranked Oracle as the number one vendor for enterprise life sciences software applications.
  • The Life Science Software Top 10 identifies the 10 leading enterprise and specialty software vendors serving the sector based on enterprise life science software license revenue.
  • The report cites Oracle's increased commitment and focus on life sciences for driving its leading share of the $2.95 billion that IDC Health Insights estimates is spent annually on software in the life sciences sector.
  • According to the report, "Oracle easily topped the chart, with nearly $60 million more than the second-place SAP."
  • The ranking is based solely on software license revenue derived from life sciences customers, and the study examined only enterprise solutions, which included: business intelligence/analytics, clinical software, customer relationship management (CRM), content management, revenue management/enterprise resource planning (ERP), human resources (HR), manufacturing, supply chain management, product lifecycle management (PLM), research and development (R&D) informatics and R&D discovery platforms.

Supporting Quotes

  • "Oracle has a proven track record as a strategic provider of complete, open and integrated software applications to the life sciences sector," said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. "Oracle's position as the number one software vendor in the life sciences sector underscores our commitment to helping customers accelerate insights for better health by enabling them to achieve greater operational efficiency and optimize performance."
  • "Oracle's fast-paced acquisition strategy, coupled with its increased commitment and focus on the life sciences via its new Health Sciences Global Business Unit has paid big dividends, which have helped to drive its success in the life science industry," wrote Eric Newmark, Research Manager, IDC Health Insights, in the report.

Supporting Resources

About Oracle

Oracle (Nasdaq: ORCL) is the world's largest business software company. For more information about Oracle, please visit our Web site at http://www.oracle.com.

Trademark

Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020718/ORCLLOGO)


'/>"/>
SOURCE Oracle Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
4. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
5. Sodexho, Inc. Announces Patrick E. Connolly as Market President & COO
6. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market
9. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
10. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and athletic trainers ... say researchers presenting their work at the American Orthopaedic Society for Sports ... evaluating the patterns of change in concussion symptom presentation, diagnostic tools used and ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid ... cancer that progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens ... reoccurrence and relapse. With such a challenging diagnosis that requires immediate action, ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
(Date:7/20/2017)... ... 2017 , ... Doctors on Liens, the leading network of medical providers working ... by Dr. Russell Horine, DC to their exclusive list of medical professionals. Horine Chiropractic ... serving as the clinic director and his son Dr. Lee Horine and daughter-in-law Dr. ...
(Date:7/20/2017)... ... July 20, 2017 , ... Using CDRH’s Medical Device Quality ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata          , Device makers have ... known as the “CY2016 Annual FDA Medical Device Quality System Data” report. CDRH ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)...  Centurion Medical Products, a leader in medical product innovation and ... removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of a ... pain while preventing unneeded emergency department admission due to severe fecal ...
(Date:7/11/2017)... Zymo Research Corp., also known as ,The Epigenetics Company, announced today the ... precise manner using the myDNAge ™ test. Based on Horvath,s Clock, ... genetics and biostatistics at the David Geffen School of Medicine at ... proprietary DNAge ™ technology is used to analyze DNA methylation patterns ... ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... development of oral drug delivery systems, announced today that ... to schedule an End-of-Phase II meeting with Oramed for ... insulin capsule ORMD-0801 in the treatment of type 2 ... endpoints by indicating a statistically significant lowering of glucose ...
Breaking Medicine Technology: